Sperm-associated antigens (SPAGs) are a group of proteins that are specifically expressed in sperm cells and have diverse roles in spermatogenesis, sperm motility, and fertilization. These proteins are often involved in the intracellular signaling pathways that regulate key physiological processes like capacitation, the acrosome reaction, and interaction with the oocyte. SPAGs can interact with other proteins, ions, or molecules inside the sperm cell to modulate its function. For example, they may be involved in calcium signaling, which is crucial for sperm motility and the acrosome reaction. Additionally, SPAGs can serve as targets for contraceptive approaches and provide further insights into fertility, although their detailed signaling mechanisms are still under active research.
Sperm-associated antigen (SPAG) inhibitors represent a specific group of chemical compounds that modulate the activity or expression of SPAGs, which are proteins highly specific to sperm cells. These inhibitors can be small molecules, peptides, or other bioactive substances that interact with SPAGs or the cellular mechanisms governing their function. The core aim of SPAG inhibitors is to interfere with the internal signaling pathways that SPAGs are involved in, such as calcium signaling, cAMP-dependent pathways, or protein-protein interactions essential for sperm motility and function. By targeting these intricate cellular pathways, SPAG inhibitors can exert their modulatory effects on key processes like sperm capacitation, the acrosome reaction, and fertilization competence.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | $105.00 $364.00 | 7 | |
Lonidamine interferes with energy metabolism in cells by inhibiting hexokinase, an enzyme critical for glycolysis. Although its primary action is not directly on SPAG6, the resultant energy depletion could theoretically impair cellular processes essential for SPAG6 function, particularly affecting its role in spermatogenesis and cilia/flagella maintenance by reducing the energy available for structural assembly and maintenance. | ||||||
Procaine | 59-46-1 | sc-296134 sc-296134A sc-296134B sc-296134C | 25 g 50 g 500 g 1 kg | $110.00 $193.00 $407.00 $628.00 | 1 | |
Procaine acts as a sodium channel blocker, leading to the inhibition of action potentials in neurons. While not directly linked to SPAG6 inhibition, the decrease in neuronal excitability could indirectly affect cellular signaling pathways that are possibly involved in the regulation of SPAG6 expression or function, especially in systems where neural signals influence ciliary movement. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP serves as a cAMP analog that can disrupt normal cellular signaling pathways by activating protein kinase A (PKA) non-specifically. This broad activation could theoretically alter the phosphorylation state of proteins involved in the regulation of SPAG6, potentially inhibiting its proper localization or function within the axoneme of cilia and flagella. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker known for its vasodilatory effects. By reducing intracellular calcium levels, it could indirectly affect calcium-dependent signaling pathways critical for the regulation of SPAG6 expression or its assembly function in the axoneme, potentially inhibiting the structural integrity of cilia and flagella. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine inhibits phosphodiesterases (PDEs), leading to increased cAMP and cGMP levels in cells. This elevation could disrupt normal signaling pathways that regulate SPAG6 function or expression, potentially leading to an inhibition of its role in cilia and flagella structure and motility. | ||||||